LMA: IPO breathes life into Singapore's bioscience ambitions

Credit Suisse First Boston and DBS have begun pre-marketing a roughly $150 million IPO for medical devices company LMA (Laryngeal Mask Airways). The deal is unusual because it has all the hallmarks of a Nasdaq IPO, but its founders have chosen to list in Singapore instead.